Response to correspondence on Differences in First-Line Chemosensitivity Assessed by KELIM in Advanced Serous Ovarian Cancer: Evidence From Western and Japanese Trials in a Gynecologic Cancer InterGroup (GCIG) Meta-analysis

International Journal of Gynecological Cancer · Published 2026-07-01 · DOI 10.1016/j.ijgc.2026.104866

Authors (2)

Pauline Corbaux, Benoit You

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Corbaux, P., You, B. (2026). Response to correspondence on Differences in First-Line Chemosensitivity Assessed by KELIM in Advanced Serous Ovarian Cancer: Evidence From Western and Japanese Trials in a Gynecologic Cancer InterGroup (GCIG) Meta-analysis. International Journal of Gynecological Cancer. https://doi.org/10.1016/j.ijgc.2026.104866

Related articles

• Beyond p53 status: the continued importance of histopathologic features for predicting lymph node metastasis in endometrial cancer · International Journal of Gynecological Cancer · 2026 · Same journal
• Integration of Immuno-Nutritional Status into International Federation of Gynecology and Obstetrics Risk Stratification to Predict Chemotherapy Response and Survival in Gestational Trophoblastic Neoplasia · International Journal of Gynecological Cancer · 2026 · Same journal
• From intensification to selection: the next challenge in advanced or recurrent endometrial cancer · International Journal of Gynecological Cancer · 2026 · Same journal
• Pre-operative Nutritional Risk Screening 2002-based nomograms for predicting post-operative complications after cytoreductive surgery for ovarian cancer: a multi-center retrospective cohort study · International Journal of Gynecological Cancer · 2026 · Same journal
• Giant vulvar plexiform neurofibroma in neurofibromatosis type 1 · International Journal of Gynecological Cancer · 2026 · Same journal
• Efficacy and safety of immune checkpoint inhibitor rechallenge in cervical and endometrial cancer: a multi-center retrospective study (RICE study) · International Journal of Gynecological Cancer · 2026 · Same journal
• Cadonilimab for recurrent small cell neuroendocrine carcinoma of the cervix: a phase 2 study · International Journal of Gynecological Cancer · 2026 · Same journal
• Association between pembrolizumab-based therapy exposure and survival outcomes in metastatic or recurrent uterine carcinosarcoma: a multicenter real-world study · International Journal of Gynecological Cancer · 2026 · Same journal
• Recognizing confounders for the use and outcome associated with intrauterine manipulator during endometrial cancer surgery: a call for research · International Journal of Gynecological Cancer · 2026 · Same journal
• External Validation of the IOTA Two-Step Strategy for Pre-operative Characterization of Adnexal Masses: Comparison with ADNEX, O-RADS and a Sequential Simple Rules–ADNEX Approach · International Journal of Gynecological Cancer · 2026 · Same journal